Dr. Robert Vonderheide

Dr. Robert Vonderheide, a leading physician-scientist and director at the Abramson Cancer Center, dives into the complexities of pancreatic cancer and immunotherapy. He discusses his evolving perspective on cancer treatment, emphasizing the unique challenges of pancreatic tumors, driven by the KRAS oncogene. Vonderheide explores innovative strategies that combine KRAS inhibitors with immunotherapies like CD40 agonists to enhance immune responses. He also highlights the critical need for early detection and the importance of fostering mentorship in the field.